E Demarsin

672 total citations
18 papers, 563 citations indexed

About

E Demarsin is a scholar working on Cancer Research, Molecular Biology and Biotechnology. According to data from OpenAlex, E Demarsin has authored 18 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Biotechnology. Recurrent topics in E Demarsin's work include Protease and Inhibitor Mechanisms (11 papers), Enzyme Production and Characterization (7 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). E Demarsin is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Enzyme Production and Characterization (7 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). E Demarsin collaborates with scholars based in Belgium. E Demarsin's co-authors include D Collen, H.R. Lijnen, Yves Laroche, B. Van Hoef, Paul Holvoet, Karen Silence, F De Cock, Els Brouwers, M De Mol and L Nelles and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

E Demarsin

18 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Demarsin Belgium 13 236 233 174 120 118 18 563
Rick D. Holly United States 7 163 0.7× 49 0.2× 165 0.9× 35 0.3× 72 0.6× 10 648
J. C. Laurent France 10 189 0.8× 36 0.2× 19 0.1× 93 0.8× 59 0.5× 14 479
Maria Unni Rømer Denmark 15 397 1.7× 244 1.0× 44 0.3× 72 0.6× 15 0.1× 26 640
Kyle D. Phipps Canada 7 245 1.0× 142 0.6× 79 0.5× 32 0.3× 15 0.1× 11 408
SE Martin United States 9 157 0.7× 28 0.1× 185 1.1× 182 1.5× 83 0.7× 15 644
Jane Mayotte United States 11 159 0.7× 70 0.3× 17 0.1× 73 0.6× 48 0.4× 14 446
Susy J. Santos Netherlands 14 230 1.0× 154 0.7× 31 0.2× 228 1.9× 59 0.5× 17 800
Antonella Facchinetti Italy 14 185 0.8× 172 0.7× 12 0.1× 117 1.0× 49 0.4× 40 546
Florencia G. Jalikis United States 9 162 0.7× 112 0.5× 18 0.1× 66 0.6× 65 0.6× 21 626
Sonja Schiffer Germany 11 151 0.6× 27 0.1× 110 0.6× 20 0.2× 128 1.1× 12 473

Countries citing papers authored by E Demarsin

Since Specialization
Citations

This map shows the geographic impact of E Demarsin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Demarsin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Demarsin more than expected).

Fields of papers citing papers by E Demarsin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Demarsin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Demarsin. The network helps show where E Demarsin may publish in the future.

Co-authorship network of co-authors of E Demarsin

This figure shows the co-authorship network connecting the top 25 collaborators of E Demarsin. A scholar is included among the top collaborators of E Demarsin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Demarsin. E Demarsin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nagai, N., et al.. (2003). Recombinant human microplasmin: production and potential therapeutic properties. Journal of Thrombosis and Haemostasis. 1(2). 307–313. 70 indexed citations
2.
Jespers, Laurent, Sophie Vanwetswinkel, H.R. Lijnen, et al.. (1999). Structural and Functional Basis of Plasminogen Activation by Staphylokinase. Thrombosis and Haemostasis. 81(4). 479–485. 26 indexed citations
3.
Bernaerts, R, Paul Declerck, F De Cock, et al.. (1996). Recombinant Staphylokinase Variants With Altered Immunoreactivity. Circulation. 94(2). 197–206. 55 indexed citations
4.
Holvoet, Paul, Berlinda Vanloo, Rita De Vos, et al.. (1995). Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants. Biochemistry. 34(41). 13334–13342. 70 indexed citations
5.
Collen, D, M De Mol, E Demarsin, F De Cock, & J M Stassen. (1993). Isolation and conditioning of recombinant staphylokinase for use in man. Fibrinolysis and Proteolysis. 7(4). 242–247. 10 indexed citations
7.
Collen, D, Karen Silence, E Demarsin, M De Mol, & H.R. Lijnen. (1992). Isolation and characterisation of natural and recombinant staphylokinase. Fibrinolysis and Proteolysis. 6(4). 203–213. 53 indexed citations
8.
Lijnen, H.R., et al.. (1992). Characterisation of rt-PA I276G, a recombinant human tissue-type plasminogen activator mutant with altered plasmin cleavage site. Fibrinolysis and Proteolysis. 6(3). 149–159. 1 indexed citations
9.
Holvoet, Paul, Yves Laroche, H.R. Lijnen, et al.. (1991). Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinase.. Journal of Biological Chemistry. 266(29). 19717–19724. 40 indexed citations
10.
Laroche, Yves, J M Stassen, Yannick Gansemans, et al.. (1991). Characterization of a recombinant single-chain molecule comprising the variable domains of a monoclonal antibody specific for human fibrin fragment D-dimer.. Journal of Biological Chemistry. 266(25). 16343–16349. 45 indexed citations
12.
Nelles, L, H.R. Lijnen, B. Van Hoef, E Demarsin, & D Collen. (1988). 262 Enzymatic properties of LYS158, LLE159 and ILE160 mutants of single-chain urokinase-type plasminogen activator. Fibrinolysis and Proteolysis. 2. 114–114. 2 indexed citations
13.
Lijnen, H.R., L Nelles, B. Van Hoef, E Demarsin, & D Collen. (1988). Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.. Journal of Biological Chemistry. 263(35). 19083–19091. 28 indexed citations
14.
Stump, DC, JM Stassen, E Demarsin, & D Collen. (1987). Comparative thrombolytic properties of single-chain forms of urokinase- type plasminogen activator. Blood. 69(2). 592–596. 23 indexed citations
15.
Gheysen, Dirk, H.R. Lijnen, L Piérard, et al.. (1987). Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.. Journal of Biological Chemistry. 262(24). 11779–11784. 33 indexed citations
17.
Collen, D, F De Cock, E Demarsin, H.R. Lijnen, & D C Stump. (1986). Absence of Synergism Between Tissue-Type Plasminogen Activator (t-PA), Single-Chain UrokinaseType Plasminogen Activator (scu-PA) and Urokinase on Clot Lysis in a Plasma Milieu In Vitro. Thrombosis and Haemostasis. 56(1). 35–39. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026